Outset Medical (OM) Cash from Investing Activities (2019 - 2026)

Outset Medical (OM) has 8 years of Cash from Investing Activities data on file, last reported at $7.9 million in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $7.9 million, up 110.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.7 million (down 113.79% YoY), and the FY2025 annual result was -$97.7 million, down 193.98% from the prior year.
• Cash from Investing Activities declined to $7.9 million in Q1 2026 per OM's latest filing, from $8.6 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $108.2 million in Q4 2024 and troughed at -$78.1 million in Q1 2025.
• A 5-year average of $1.8 million and a median of $7.9 million in 2026 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities surged 2163.3% in 2023, then tumbled 2333.48% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$51.7 million in 2022, then surged by 145.27% to $23.4 million in 2023, then soared by 361.7% to $108.2 million in 2024, then sank by 92.06% to $8.6 million in 2025, then dropped by 8.04% to $7.9 million in 2026.
• Business Quant data shows OM's Cash from Investing Activities at $7.9 million in Q1 2026, $8.6 million in Q4 2025, and $3.0 million in Q3 2025.